HIV’s genome of RNA includes the code for reverse transcript…

HIV’s genome of RNA includes the code for reverse transcriptase (RT), an enzyme that acts early in infection to synthesize a DNA genome off of an RNA template. The HIV genome also codes for protease (PR), an enzyme that acts later in infection by cutting long viral polyproteins into smaller, functional proteins. Both RT and PR represent potential targets for antiretroviral drugs. Drugs called nucleoside analogs (NA) act against RT, whereas drugs called protease inhibitors (PI) act against PR.   Which of the following represents the treatment option most likely to avoid the production of drug-resistant HIV (assuming no drug interactions or side effects)?